DAVITA INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
DAVITA INC. (DVA) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of 0.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-11
- DAVITA INC. effective income tax rate reconciliation, tax contingency, percent for fiscal 2025 was 0.70%.
- DAVITA INC. effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was -0.60%.
- DAVITA INC. effective income tax rate reconciliation, tax contingency, percent for fiscal 2023 was -1.10%.
- DAVITA INC. effective income tax rate reconciliation, tax contingency, percent for fiscal 2022 was -1.10%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.70% 10-K · filed 2026-02-11 | |
| 2024-12-31 | -0.60% 10-K · filed 2026-02-11 | -0.50% 10-K · filed 2025-02-13 |
| 2023-12-31 | -1.10% 10-K · filed 2026-02-11 | |
| 2022-12-31 | -1.10% 10-K · filed 2025-02-13 | |
| 2021-12-31 | -0.10% 10-K · filed 2024-02-14 | |
| 2020-12-31 | 0.40% 10-K · filed 2023-02-22 | |
| 2019-12-31 | 2.40% 10-K · filed 2022-02-11 | |
| 2018-12-31 | 0.20% 10-K · filed 2021-02-12 | |
| 2017-12-31 | 0.10% 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |